Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
28.96
-1.00 (-3.34%)
Last updated: Jul 16, 2026, 10:39 AM HKT

HKG:9637 Statistics

Total Valuation

HKG:9637 has a market cap or net worth of HKD 10.18 billion. The enterprise value is 10.20 billion.

Market Cap10.18B
Enterprise Value 10.20B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

HKG:9637 has 339.85 million shares outstanding.

Current Share Class 227.12M
Shares Outstanding 339.85M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.33%
Owned by Institutions (%) 23.09%
Float 103.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 299.44
PB Ratio 18.18
P/TBV Ratio 18.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 1.09.

Current Ratio 2.33
Quick Ratio 2.22
Debt / Equity 1.09
Debt / EBITDA n/a
Debt / FCF -1.41
Interest Coverage -5.85

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -33.01%
Return on Invested Capital (ROIC) -424.12%
Return on Capital Employed (ROCE) -58.79%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.02
Inventory Turnover 2.09

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 2,141,756

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:9637 had revenue of HKD 34.00 million and -834.65 million in losses. Loss per share was -3.42.

Revenue34.00M
Gross Profit 14.96M
Operating Income -719.72M
Pretax Income -836.63M
Net Income -834.65M
EBITDA -675.69M
EBIT -719.72M
Loss Per Share -3.42
Full Income Statement

Balance Sheet

The company has 592.02 million in cash and 611.40 million in debt, with a net cash position of -19.38 million or -0.06 per share.

Cash & Cash Equivalents 592.02M
Total Debt 611.40M
Net Cash -19.38M
Net Cash Per Share -0.06
Equity (Book Value) 560.01M
Book Value Per Share 1.98
Working Capital 354.86M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -320.36 million and capital expenditures -113.09 million, giving a free cash flow of -433.45 million.

Operating Cash Flow -320.36M
Capital Expenditures -113.09M
Depreciation & Amortization 45.82M
Net Borrowing 31.24M
Free Cash Flow -433.45M
FCF Per Share -1.28
Full Cash Flow Statement

Margins

Gross Margin 44.00%
Operating Margin -2,116.64%
Pretax Margin -2,460.46%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:9637 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -8.20%
FCF Yield -4.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:9637 has an Altman Z-Score of -2.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.71
Piotroski F-Score 1